Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds

Area of Science:

• Ophthalmology
• Oncology
• Molecular Biology

Background:

• Vitreous seeding is a major cause of treatment failure in retinoblastoma (Rb).
• Current treatments like chemotherapy have limitations and complications.
• Developing targeted therapies for Rb vitreous seeds is crucial.

Purpose of the Study:

• To investigate the role of the platelet-derived growth factor (PDGF)-PDGF-receptor β (PDGFRβ) signaling pathway in Rb seed growth.
• To evaluate the impact of targeting this pathway on Rb cell apoptosis and invasiveness.

Main Methods:

• Ex vivo analysis of Rb patient vitreous samples and xenografts using qPCR, immunohistochemistry, and ELISA.
• In vitro studies involving pharmacologic and genomic knockdown of the PDGF-PDGFRβ pathway.
• Development of a novel 3D cell culture system to mimic Rb seeds.

Main Results:

• PDGFRβ signaling is active in Rb vitreous, promoting cell growth and survival via AKT, MDM2, and NF-κB.
• The 3D cell culture system effectively models Rb seed morphology and physiology.
• Inhibition of PDGFRβ reduced Rb cell proliferation, survival, and invasiveness in vitro.

Conclusions:

• Targeting the PDGFRβ pathway is a potential novel therapeutic strategy for retinoblastoma.
• This approach may enhance current treatments and improve ocular survival in advanced Rb.